Literature DB >> 7460993

Biochemical evaluation of patients with urolithiasis.

H G Tiselius, L Larsson.   

Abstract

Inhibition of calcium oxalate crystal growth was analyzed in 84 male and 30 female patients with urolithiasis and in 27 normal men and 7 normal women. No significant difference in inhibition index was found between stone formers and normal subjects or between male and female stone formers. The quotient, calcium X oxalate/magnesium X inhibition index, was significantly higher in urine from male stone formers (p less than 0.01) and the same was found for the quotient, calcium X oxalate/magnesium X citrate X inhibition index (p less than 0.005).

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7460993     DOI: 10.1159/000473168

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  9 in total

1.  Can a relationship reflect the risk of calcium oxalate urolithiasis?

Authors:  P Roca; A Conte; T Riera; F Grases
Journal:  Int Urol Nephrol       Date:  1990       Impact factor: 2.370

2.  A proposed method for approximate estimates of the ion-activity products of calcium oxalate and calcium phosphate in spot-urine samples or in urine samples collected during less well defined periods of time.

Authors:  Hans-Göran Tiselius
Journal:  Urolithiasis       Date:  2013-02-06       Impact factor: 3.436

3.  Measurement of the risk of calcium phosphate crystallization in urine.

Authors:  H G Tiselius
Journal:  Urol Res       Date:  1987

4.  Risk factors of calcium stone formation in patients with primary Sjögren's syndrome.

Authors:  P Eriksson; T Denneberg; H G Tiselius
Journal:  Urol Res       Date:  1996

Review 5.  Caffeine in Kidney Stone Disease: Risk or Benefit?

Authors:  Paleerath Peerapen; Visith Thongboonkerd
Journal:  Adv Nutr       Date:  2018-07-01       Impact factor: 8.701

6.  Inhibition of calcium oxalate crystallization by urinary macromolecules.

Authors:  H Bek-Jensen; H G Tiselius
Journal:  Urol Res       Date:  1991

7.  Measurement of the risk of calcium oxalate crystallization in urine.

Authors:  H G Tiselius
Journal:  Urol Res       Date:  1985

8.  Using verapamil as protective factor in renal ischemia reperfusion injury during anatrophic nephrolithotomy.

Authors:  Damir Aganović; Benjamin Kulovac; Alden Prcić; Osman Hadziosmanović
Journal:  Bosn J Basic Med Sci       Date:  2007-08       Impact factor: 3.363

Review 9.  Methods for diagnosing the risk factors of stone formation.

Authors:  William G Robertson
Journal:  Arab J Urol       Date:  2012-05-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.